Published in Medical Device Business Week, September 29th, 2004
Kishbauch replaces interim CEO, Marios Fotiadis. Achillion also announced the close of a $10.4 million financing from existing investors.
"Michael Kishbauch brings over 22 years of healthcare leadership to Achillion including substantial experience in corporate operations, product development, regulatory affairs, multiple product launches and innovative product marketing," said James M. Garvey, of Schroder Ventures Life Sciences and chairman of Achillion's board of directors. "We are excited that Michael is joining Achillion and believe that our Company will...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.